bioAffinity Technologies, Inc. (BIAF) — Financial Flexibility Index
bioAffinity Technologies, Inc. (BIAF) has a Financial Flexibility Index of -0.68x as of December 2025. Free cash flow of $-2.50 Million (operating CF $-2.56 Million minus capex $60.56K) represents -1% of total liabilities ($3.68 Million). Check BIAF PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
bioAffinity Technologies, Inc. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for bioAffinity Technologies, Inc. across 7 annual periods. See bioAffinity Technologies, Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for bioAffinity Technologies, Inc. (2019–2025)
Year-by-year free cash flow to debt coverage for bioAffinity Technologies, Inc.. For the full company profile including market capitalisation, see bioAffinity Technologies, Inc. market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.52x | $-9.27 Million | $-9.33 Million | $3.68 Million | ▼ -37.0% |
| 2024 | -1.84x | $-7.19 Million | $-7.26 Million | $3.91 Million | ▼ -2.8% |
| 2023 | -1.79x | $-6.01 Million | $-6.04 Million | $3.37 Million | ▲ +47.2% |
| 2022 | -3.38x | $-3.85 Million | $-4.07 Million | $1.14 Million | ▼ -2746.1% |
| 2021 | -0.12x | $-2.05 Million | $-2.05 Million | $17.24 Million | ▲ +18.0% |
| 2020 | -0.14x | $-2.20 Million | $-2.21 Million | $15.22 Million | ▲ +72.6% |
| 2019 | -0.53x | $-2.48 Million | $-2.49 Million | $4.69 Million | — |